Isolated Central Nervous System blast crisis in chronic myeloid leukemia: A rare case report

Chronic myeloid leukemia (CML) is a triphasic myeloproliferative neoplasm, characterized by the presence of the Philadelphia chromosome Ph+ (BCRABL fusion gene- t(9:22)), and most cases of CML manifest in the chronic phase with a high granulocyte count, while 5-10% progress to accelerated or blast crisis. Infiltration of the central nervous system as the only site of extramedullary blast crisis without bone marrow involvement is uncommon and deserves scrutiny. In such cases, a blast crisis could present with either myeloid or lymphoid infiltration, resulting in acute myeloid leukemia or acute lymphoid leukemia, respectively. Imatinib mesylate has promising activity in patients with Ph+ acute leukemias; however, its CNS penetration is poor. We report a 43-year-old male with CML-CP who developed isolated CNS blast crisis with an Early T-cell Precursor Acute Lymphoblastic Leukemia (ETP-ALL) phenotype, and discuss the diagnostic and therapeutic approach.

Authors

Institutions

Publication Details

Journal
Asian Journal of Oncology
Published
2025-11-14
DOI
https://doi.org/10.25259/asjo_9_2025
Primary Topic
Chronic Myeloid Leukemia Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Isolated Central Nervous System blast crisis in chronic myeloid leukemia: A rare case report

Kunal Sehgal, Manjusha Ray, Disha Morzaria, U. Maheshwari et al.
Asian Journal of Oncology
Chronic Myeloid Leukemia Treatments
article

Isolated Central Nervous System blast crisis in chronic myeloid leukemia: A rare case report

Kunal Sehgal, Manjusha Ray, Disha Morzaria, U. Maheshwari, Vashishth Maniar, Vasudha Kaul
article en

Abstract

Chronic myeloid leukemia (CML) is a triphasic myeloproliferative neoplasm, characterized by the presence of the Philadelphia chromosome Ph+ (BCRABL fusion gene- t(9:22)), and most cases of CML manifest in the chronic phase with a high granulocyte count, while 5-10% progress to accelerated or blast crisis. Infiltration of the central nervous system as the only site of extramedullary blast crisis without bone marrow involvement is uncommon and deserves scrutiny. In such cases, a blast crisis could present with either myeloid or lymphoid infiltration, resulting in acute myeloid leukemia or acute lymphoid leukemia, respectively. Imatinib mesylate has promising activity in patients with Ph+ acute leukemias; however, its CNS penetration is poor. We report a 43-year-old male with CML-CP who developed isolated CNS blast crisis with an Early T-cell Precursor Acute Lymphoblastic Leukemia (ETP-ALL) phenotype, and discuss the diagnostic and therapeutic approach.

Asian Journal of OncologyVol. 11
Ajanta Pharma (India) (IN), HCG Cancer Centre (IN)
Openalex Percentile: Top 55%
Chronic Myeloid Leukemia Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.